Enoxaparin sodium and Lanoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enoxaparin sodium (enoxaparin sodium) and Lanoxin (digoxin). Common drug interactions include bladder cancer recurrent among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Enoxaparin sodium and Lanoxin. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

On Jul, 20, 2026

47 people who take Enoxaparin sodium and Lanoxin together, and have interactions are studied.

Enoxaparin sodium and Lanoxin drug interactions.

What are the common drug interactions of Enoxaparin Sodium and Lanoxin, by gender? *:

female:

Bladder cancer recurrent
Bradycardia (abnormally slow heart action)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Renal failure (kidney dysfunction)
Abdominal pain
Abdominal wall haematoma (abdominal wall blood clotting)
Asthenia (weakness)
Blood pressure decreased
Cardiac failure congestive
Chest pain

male:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Rectal haemorrhage (bleeding from anus)
Cough
Dyspnoea (difficult or laboured respiration)
Fall
Fatigue (feeling of tiredness)
Haematuria (presence of blood in urine)
Hypertension (high blood pressure)
Hypoxia (low oxygen in tissues)
International normalised ratio increased

What are the common drug interactions of Enoxaparin Sodium and Lanoxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Haemorrhage (bleeding)
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Coma (state of unconsciousness lasting more than six hours)

20-29:

n/a

30-39:

n/a

40-49:

Diarrhoea
Hypotension (abnormally low blood pressure)
Somnolence (a state of near-sleep, a strong desire for sleep)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

Dizziness
Gastric ulcer perforation (stomach hole due to ulcer)

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Rectal haemorrhage (bleeding from anus)
Renal failure (kidney dysfunction)
Abdominal infection
Acute respiratory failure
Anaemia (lack of blood)
Anticoagulation drug level above therapeutic
Blood pressure decreased
Cardiac failure
Cardiac failure congestive

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 8.51%
Candidiasis (candidiasis or thrush is a fungal infection): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Enoxaparin sodium and Lanoxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously